Lv1
10 积分 2024-04-28 加入
Abstract 6764: Comparative profiling of TEAD palmitoylation and YAP-TEAD protein-protein interaction inhibitors as combination agents with KRAS inhibitors
3个月前
已完结
Cyclovirobuxine D inhibits triple-negative breast cancer via YAP/TAZ suppression and activation of the FOXO3a/PINK1-Parkin pathway-induced mitophagy
3个月前
已完结
Efficient proximity labeling in living cells and organisms with TurboID
4个月前
已完结
STK25: a viable therapeutic target for cancer treatments?
10个月前
已完结
Production of hesperetin from naringenin in an engineered Escherichia coli consortium
1年前
已完结
Production of hesperetin from naringenin in an engineered Escherichia coli consortium
1年前
已完结
皖公网安备34019202002308
